This inventor holds 1 USPTO granted patent. Top assignee: Ranok Therapeutics (Hangzhou) Co. Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Kevin Foley - Innovator in Targeted Protein Degradation
Introduction
Kevin Foley is a notable inventor based in Waltham, MA (US). He has made significant contributions to the field of biotechnology, particularly in the area of targeted protein degradation. His work is aimed at developing innovative solutions for treating cancers and related conditions.
Latest Patents
Kevin Foley holds 1 patent for his invention titled "Methods and compositions for targeted protein degradation." This patent includes compounds of Formula I and pharmaceutically acceptable salts and compositions that are useful in the treatment of various cancers.
Career Highlights
Kevin is currently associated with Ranok Therapeutics, a company that focuses on advancing therapeutic solutions. His role at the company allows him to leverage his expertise in biotechnology and contribute to groundbreaking research.
Collaborations
Throughout his career, Kevin has collaborated with talented individuals such as Weiwen Ying and Long Ye. These collaborations have further enriched his research and development efforts in the field.
Conclusion
Kevin Foley's innovative work in targeted protein degradation exemplifies the impact of dedicated inventors in the biotechnology sector. His contributions are paving the way for new treatments in cancer therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile